Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2014-10-01

Clinical Trial Update: Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)

View source ↗

Summary

Clinical trial update noting birth defects associated with exposure to lamotrigine during pregnancy based on EUROCAT data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: COMPLETED